EUVIMEDSkopri EUVIMED
Open access

Dopamine depletion in Parkinson’s increases directed but not random exploration

Björn Meder iD, Martha Sterf, Charley M Wu, Matthias Guggenmos iD

Science Advances · 2026-08-07 · 12 (32)

DOI: 10.1126/sciadv.aee6556 ↗

At a glance

Journal article in Science Advances, published on 2026-08-07. Written by Björn Meder and 3 co-authors. Institution: Institute for Mind, Brain, and Behavior, Health and Medical University, Olympischer Weg 1, 14471 Potsdam, Germany. Major MEDLINE topics: Parkinson Disease, Dopamine, Exploratory Behavior. 69 references. The full text is freely available in PubMed Central. Funded by: Deutsche Forschungsgemeinschaft, Hessisches Ministerium für Wissenschaft und Kunst.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

We investigated how patients with Parkinson’s disease (PD) manage the explore-exploit trade-off in a structured reward-learning task. Patients were tested either on ( n = 34) or off ( n = 34) dopaminergic medication (levodopa), with age-matched polyneuropathy patients serving as controls ( n = 35). Behaviorally, patients off medication showed marked learning and decision-making deficits, characterized by overexploration (excessive sampling of novel options) and insufficient exploitation (re-selection of previously rewarding options). To clarify the underlying mechanisms, we applied a Gaussian process–upper confidence bound (GP-UCB) model that combines generalization across spatially similar options with uncertainty-directed exploration (targeted sampling of uncertain options) and random exploration (undirected choice variability). Modeling results showed that patients off medication exhibited increased uncertainty-directed exploration compared to both controls and patients with PD on medication, whereas random exploration did not differ across groups. Relative to controls, patients off medication also showed reduced generalization. In contrast, directed exploration and generalization in patients on medication were comparable to the control group. Our findings highlight how dopamine depletion in PD affects reward learning under uncertainty, suggesting a key role of dopamine in exploration and generalization.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseDopamineExploratory BehaviorHumansMaleFemaleAgedRewardMiddle AgedDecision MakingLearningLevodopaCase-Control Studies

Substances

DopamineLevodopa

Authors and institutions

  • Institute for Mind, Brain, and Behavior, Health and Medical University, Olympischer Weg 1, 14471 Potsdam, Germany.
  • Medical School Berlin, Rüdesheimer Str. 50, 14197 Berlin, Germany.
  • Human and Machine Cognition Lab, University of Tübingen, Maria-von-Linden-Str. 6, 72074 Tübingen, Germany.
  • Institute of Psychology, Technical University of Darmstadt, Karolinenplatz 5, 64289 Darmstadt, Germany.
  • Hessian.AI, Landwehrstraße 50A, 64293 Darmstadt, Germany.
  • Bernstein Center for Computational Neuroscience Berlin, Philippstraße 13, 10115 Berlin, Germany.

ORCID profiles: Björn Meder, Matthias Guggenmos

Funding

  • Deutsche Forschungsgemeinschaft
  • Hessisches Ministerium für Wissenschaft und Kunst

Cite

APA

Meder, B., Sterf, M., Wu, C. M., & Guggenmos, M. (2026). Dopamine depletion in Parkinson’s increases directed but not random exploration. Science Advances, 12(32). https://doi.org/10.1126/sciadv.aee6556

Vancouver

Meder B, Sterf M, Wu CM, Guggenmos M. Dopamine depletion in Parkinson’s increases directed but not random exploration. Science Advances. 2026;12(32). doi:10.1126/sciadv.aee6556

BibTeX
@article{Meder2026,
  author = {Meder, Björn and Sterf, Martha and Wu, Charley M and Guggenmos, Matthias},
  title = {Dopamine depletion in Parkinson’s increases directed but not random exploration},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {32},
  doi = {10.1126/sciadv.aee6556}
}
Start for free →